8-K filing — SOLESENCE, INC. (SLSN)
Filed: 2026-10-05 AccNo: 0001171843-26-006412 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Solesence (NASDAQ:SLSN) reported $15.332 million in sales this quarter. This is a 24.69 percent decrease over sales of $20.359 million the same period last year.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-05 AccNo: 0001171843-26-006412 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Solesence (NASDAQ:SLSN) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data